Navigation Links
New partnership offers outsourced R&D in membrane biology
Date:9/24/2007

One of the UK's most successful academic entrepreneurs has teamed up with the University of Leeds to offer outsourced research and development in membrane biology to pharmaceutical, biotech and agrochemical companies.

Dr Tony Marchington, who turned his spin-out company Oxford Molecular into a business worth 450m, will work alongside the Universitys new Centre for Integrative Membrane Biology (CIMB) to broker research contracts with industry, based on Leeds world-class expertise in membrane biology.

Membrane biology research is central to the improved treatment of human disease with pharmaceutical drugs; currently around 75 per cent of current drugs have their effects via membrane proteins(1).

The partnership between CIMB, based at the Universitys Faculty of Biological Sciences, and M2 Ventures - Dr Marchingtons new company set up with finance expert Martin Manning - will offer a co-ordinated expert research resource to industry addressing membrane function at all levels: the biology of single cells through to whole organisms; analysis of protein structure and function; membranes on devices and high throughput interrogation platforms, such as for sensor technologies.

Says Dr Marchington: As the pharma and healthcare industries continue the trend to outsource their fundamental research and early stage development, the natural recipients of this work are universities, such as Leeds, that have both research excellence in these areas and can package and offer that expertise in ways that meet industry requirements.

Its self-evident that Leeds has exceptional breadth of expertise including world-class research capability in membrane biology; and as the market for targeted drugs accelerates, we believe that there will be great demand for their services. With our combined knowledge, experience and contacts, we are in a formidable position to capitalise on the strengths of this partnership.

The partnership was brokered by Leeds Professors Deborah Withington and John Colyer both of whom have extensive commercial experience. Professor Withington said: This partnership has all the hallmarks of something very special and were excited by its potential.


'/>"/>

Contact: Jo Kelly
jokelly@campuspr.co.uk
44-011-325-89880
University of Leeds
Source:Eurekalert

Related biology news :

1. Nonlinear Dynamics announces more details of its global partnership with PerkinElmer
2. New partnership to clear landmines for African Elephants
3. Gut microbes partnership helps body extract energy from food, store it as fat
4. Protein offers way to stop microscopic parasites in their tracks
5. World-first Living Donor Islet Cell Transplant A Success; Procedure Offers Promise For Diabetics
6. Gene silencing technique offers new strategy for treating, curing disease
7. Mosaic mouse technique offers a powerful new tool to study diseases and genetics
8. Drug Offers Alternative to Surgical Treatment After Miscarriage
9. Transgenic goats milk offers hope for tackling childrens intestinal disease
10. Engineered skin offers clues to melanoma development
11. GM crop that holds on to its seeds offers higher yields
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... 2016 Vigilant Solutions announces today that an agency ... develop a lead in a difficult homicide case. The agency ... locate the suspect vehicle. Due to the ongoing investigation, the ... omitted at the agency,s request. --> ... victim was found deceased at an intersection here in the ...
(Date:2/5/2016)... 5, 2016 http://www.researchandmarkets.com/research/5kvw8m/global_facial ... "Global Facial Recognition Market 2016-2020" ... http://www.researchandmarkets.com/research/5kvw8m/global_facial ) has announced the addition of ... report to their offering. --> ... has announced the addition of the ...
(Date:2/3/2016)... GOTHENBURG, Sweden , February 4, 2016 ... Revenues amounted to SEK 1,351.5 M (105.0), up 1,187% compared with fourth ... Operating profit amounted to SEK 517.6 M (loss: 30.0). Earnings ... from operating activities was SEK 537.4 M (neg: 74.7). , ... , Revenues amounted to SEK 2,900.5 M (233.6), up 1,142% ...
Breaking Biology News(10 mins):
(Date:2/9/2016)... YORK , Feb. 9, 2016 This ... analyzes the current and future prospects of the market ... this report include companies engaged in the manufacture of ... an executive summary with a market snapshot providing the ... scope of this report. This section also provides the ...
(Date:2/8/2016)... 8, 2016 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or ... finalists for clean technology companies in the TSX Venture 50 ... companies listed on the TSX Venture Exchange, in each of ... clean technology & life sciences, diversified industries and technology ... to return on investment, market cap growth, trading volume and ...
(Date:2/8/2016)... ... February 08, 2016 , ... Thomas ... is the Executive Vice President for Corporate Services and the Chief Financial Officer ... Payable, Payroll, Billing Operations, Treasury, Managed Care Contracting, Supply Chain, and Investments. , ...
(Date:2/8/2016)... , Feb. 8, 2016  NanoViricides, Inc. (NYSE MKT: NNVC) (the ... Eugene Seymour , MD, MPH, will present information about the ... Waldorf-Astoria Hotel in New York City . ... in the Windsor Room at 5:30PM EST. Registered attendees can request ... New York City . --> New ...
Breaking Biology Technology: